CALIFORNIA HEART CENTER FOUNDATION: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization
CALIFORNIA HEART CENTER FOUNDATION (EIN 95-4772979)
Tax period
2019-01-01 to 2019-12-31
Filed
2020-11-13
IRS object ID
202033189349312693
Schema version
2019v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2020-11-13T18:50:46-06:00ReturnTs
Tax Period End2019-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN346565596PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1ERNST & YOUNG US LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line118101 VON KARMAN AVENUE SUITE 1700AddressLine1Txt
CityIRVINECityNm
State AbbreviationCAStateAbbreviationCd
ZIP92612ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2019-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN954772979EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1CALIFORNIA HEART CENTER FOUNDATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlCALIBusinessNameControlTxt
Phone3102488327PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line18536 WILSHIRE BOULEVARD SUITE 301AddressLine1Txt
CityBEVERLY HILLSCityNm
State AbbreviationCAStateAbbreviationCd
ZIP90211ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonJON KOBASHIGAWA MDPersonNm
Person TitlePRESIDENTPersonTitleTxt
Phone3102488327PhoneNum
Signature2020-11-13SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonKARA ADAMSPreparerPersonNm
PTINP00023315PTIN
Phone9497942300PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address163.116.132.115IPv4AddressTxt
FieldValueIRS element (for citing)
IP2020-11-13IPDt
IP Tm16:44:28IPTm
IP TimezonePSIPTimezoneCd
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device Id5D66495798EA847DC80F6602DD5A7F057B72F91FAtSubmissionCreationDeviceId
At Submission Filing Device Id06B79B3CF97A39592A6D2AF2C723A31CE5AEA88BAtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2019TaxYr
Build TS2021-01-29 14:40:06ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerJON KOBASHIGAWA MDPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line18536 WILSHIRE BOULEVARD SUITE 301AddressLine1Txt
CityBEVERLY HILLSCityNm
State AbbreviationCAStateAbbreviationCd
ZIP90211ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$2,210,596GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.CALHEART.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2000FormationYr
Legal Domicile StateCALegalDomicileStateCd
Activity Or MissionPROMOTE & DEVELOP EDUCATIONAL & SCIENTIFIC RESEARCH TO ADVANCE THE FIELD OF CARDIOVASCULAR MEDICINE.ActivityOrMissionDesc
Voting Members Governing Body5VotingMembersGoverningBodyCnt
Voting Members Independent3VotingMembersIndependentCnt
Total Employee0TotalEmployeeCnt
Total Volunteers3TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$1,603,657PYContributionsGrantsAmt
CY Contributions Grants$1,944,292CYContributionsGrantsAmt
PY Program Service Revenue$221,768PYProgramServiceRevenueAmt
CY Program Service Revenue$266,304CYProgramServiceRevenueAmt
PY Investment Income$0PYInvestmentIncomeAmt
CY Investment Income$0CYInvestmentIncomeAmt
PY Other Revenue$3,813PYOtherRevenueAmt
CY Other Revenue$0CYOtherRevenueAmt
PY Total Revenue$1,829,238PYTotalRevenueAmt
CY Total Revenue$2,210,596CYTotalRevenueAmt
PY Grants And Similar Paid$0PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$0CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$1,399,820PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$1,599,359CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$490,463PYOtherExpensesAmt
CY Other Expenses$601,968CYOtherExpensesAmt
PY Total Expenses$1,890,283PYTotalExpensesAmt
CY Total Expenses$2,201,327CYTotalExpensesAmt
PY Revenues Less Expenses-$61,045PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$9,269CYRevenuesLessExpensesAmt
Total Assets BOY$43,775TotalAssetsBOYAmt
Total Assets EOY$79,180TotalAssetsEOYAmt
Total Liabilities BOY$207,993TotalLiabilitiesBOYAmt
Total Liabilities EOY$234,130TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY-$164,218NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY-$154,950NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE MISSION OF THE CALIFORNIA HEART CENTER FOUNDATION IS TO ADVANCE THE FIELD OF CARDIOVASCULAR MEDICINE THROUGH CLINICAL RESEARCH INITIATIVES AND EDUCATIONAL INITIATIVES.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$1,954,029ExpenseAmt
Grant$0GrantAmt
Revenue$266,304RevenueAmt
DescTHE MISSION OF THE CALIFORNIA HEART CENTER FOUNDATION IS TO ADVANCE THE FIELD OF CARDIOVASCULAR MEDICINE THROUGH CLINICAL RESEARCH INITIATIVES AND EDUCATIONAL INITIATIVES. OUR EFFORTS INCLUDE THE PURSUIT OF COLLABORATIVE RESEARCH PROJECTS WHICH PROMOTE A DEEPER UNDERSTANDING OF DISEASE PROGRESSION AND TEST THE EFFICACY OF NEW STRATEGIES FOR DIAGNOSIS AND TREATMENT. AREAS OF RESEARCH CURRENTLY BEING PURSUED INCLUDE NON-INVASIVE METHODS TO DETECT ORGAN REJECTION, NOVEL IMMUNOSUPPRESSIVE AGENTS, IMMUNE MONITORING STRATEGIES, LONG-TERM COMPLICATIONS SUCH AS CARDIAC ALLOGRAFT VASCULOPATHY, (CONTINUED ON SCHEDULE O)(CONTINUATION FROM FORM 990, PAGE 2)NOVEL METHODS FOR ORGAN PROCUREMENT AND PRESERVATION, NEW MECHANICAL CIRCULATORY SUPPORT DEVICES AND PULMONARY HYPERTENSION. THE ORGANIZATION ALSO SUPPORTS IMPORTANT SCIENTIFIC SYMPOSIA, WHICH ALLOW FOR THE EXCHANGE OF IDEAS AMONG LEADERS IN THE FIELD AND PROVIDE A FORUM FOR EXPERTS TO SHARE THEIR EXPERIENCE AND KNOWLEDGE WITH OTHER PRACTITIONERS. THE ORGANIZATION RESOURCES ARE ALSO LEVERAGED TO SUPPORT A SUMMER RESEARCH INTERNSHIP PROGRAM FOR UNDERGRADUATE STUDENTS WITH AN INTEREST IN MEDICINE AND/OR ACADEMIC RESEARCH. FOLLOWING IS A SUMMARY OF PROJECTS AND PROGRAMS IMPLEMENTED IN 2019: SCIENTIFIC FORUMS AND EDUCATIONAL ACTIVITIES:* "CUTTING EDGE OF TRANSPLANTATION (CEOT)" - FEBRUARY 21-23, 2019 (PHOENIX AZ)THIS CONFERENCE WAS ORGANIZED BY THE AMERICAN SOCIETY OF TRANSPLANTATION, WITH CONTENT DEVELOPED AROUND THE THEMATIC FOCUS OF "NO SIZE FITS ALL: UNCOVERING THE POTENTIAL OF PERSONALIZED TRANSPLANTATION". DEDICATED HEART AND LUNG SESSIONS WERE DESIGNED, ORGANIZED AND CHAIRED BY DR. KOBASHIGAWA, WITH A FOCUS ON CUSTOMIZED IMMUNOSUPPRESSION AND BIOMARKERS FOR ORGAN REJECTION. THE INTERACTIVE SESSIONS ATTRACTED 100 PARTICIPANTS AND INCLUDED A HIGHLY ACCLAIMED EXPERT FACULTY, A MENTORED CASE STUDY SESSION FOR FELLOWS AND NETWORKING OPPORTUNITIES.* "CONSENSUS CONFERENCE ON HEART/KIDNEY TRANSPLANTATION" - SATURDAY, JUNE 1ST, 2019 (BOSTON, MA)JOINTLY SPONSORED BY THE AST THORACIC AND CRITICAL CARE COMMUNITY OF PRACTICE, THE KIDNEY PANCREAS COMMUNITY OF PRACTICE, AND CEDARS-SINAI SMIDT HEART INSTITUTE, THIS CONSENSUS CONFERENCE WAS HELD JUST PRIOR TO THE 2019 AMERICAN TRANSPLANT CONGRESS. DESIGNED TO PROVIDE A FORUM FOR AN IN-DEPTH DISCUSSION AMONG THE LEADING EXPERTS IN THE FIELD, INCLUDING NEPHROLOGISTS, CARDIOLOGISTS, AND TRANSPLANT SURGEONS, THIS CONFERENCE SERVED AS A FIRST STEP IN DEVELOPING NEEDED GUIDELINES FOR THE INTERDISCIPLINARY CRITERIA FOR KIDNEY TRANSPLANTATION IN THE COMBINED HEART/KIDNEY TRANSPLANT CANDIDATE, EVALUATE THE CURRENT ALLOCATION OF KIDNEYS TO FOLLOW THE HEART FOR THE HEART/KIDNEY TRANSPLANT RECIPIENT AND RECOMMEND STANDARDIZED CARE FOR THE COLLABORATIVE MANAGEMENT OF HEART/KIDNEY TRANSPLANT RECIPIENTS. A CONSENSUS STATEMENT IS CURRENTLY BEING DRAFTED, WITH PUBLICATION EXPECTED BY THE END OF THIS CALENDAR YEAR.* CARDIAC AMYLOID CONSORTIA - INVESTIGATOR MEETINGS - MONDAY, MARCH 18TH, 2019 (NEW ORLEANS, LA) AND WEDNESDAY, APRIL 3RD, 2019 (ORLANDO, FL)TWO BRAINSTORMING MEETINGS REGARDING THE ESTABLISHMENT OF A CONSORTIUM TO SUPPORT A MULTI-CENTER AMYLOID REGISTRY WERE HELD IN TANDEM WITH THE AMERICAN COLLEGE OF CARDIOLOGY AND INTERNATIONAL SOCIETY OF HEART & LUNG TRANSPLANTATION IN THE SPRING OF THIS YEAR. BOTH MEETINGS WERE ORGANIZED BY DR. JIGNESH PATEL AND SPONSORED BY DR. JON KOBASHIGAWA. THE MEETINGS PROVIDED A FORUM FOR EXPERTS IN THIS RARE DISEASE TO DISCUSS AND DEVELOP A NEW CONSORTIUM TO PURSUE COLLABORATIVE RESEARCH, INCLUDING THE INITIATION OF A MULTI-CENTER REGISTRY STUDY.* OPTIMAL CARE AND NEW THERAPIES IN ADVANCED HEART DISEASE (LAS VEGAS, NV) SEPTEMBER 7TH, 2019THIS 1-DAY SYMPOSIUM ON ADVANCED HEART DISEASE TOOK PLACE ON SATURDAY, SEPTEMBER 7TH, 2019 AT THE MGM GRAND HOTEL CONFERENCE CENTER IN LAS VEGAS. THE PROGRAM FEATURED PRESENTATIONS ON TOPICS RELATED TO THE DIAGNOSIS AND TREATMENT OF HEART FAILURE, TRANSPLANTATION, MECHANICAL CIRCULATORY SUPPORT AND PULMONARY HYPERTENSION. THE PROGRAM WAS ATTENDED BY 40 PARTICIPANTS, INCLUDING COMMUNITY CARDIOLOGISTS IN THE LOCAL AREA.* DSL/THOMAS D. GORDON VISITING PROFESSOR IN ADVANCED HEART DISEASE (LOS ANGELES, CA) SEPTEMBER 23RD-24TH, 2019THIS YEAR'S VISITING PROFESSOR WAS DR. SHARON HUNT. WITH A CAREER AT STANFORD SPANNING OVER FIFTY YEARS, DR. HUNT HAS WITNESSED THE HISTORY OF HEART TRANSPLANT SURGERY FROM THE VERY FIRST ONE IN THE US BY NORMAN SHUMWAY IN 1968, THROUGH THE INTERNATIONAL MORATORIUM ON HEART TRANSPLANTS AND THE RECENT DECADES OF COMBINED HEART-LUNG TRANSPLANTS AND MECHANICAL ASSIST DEVICES. SHE IS A PAST PRESIDENT OF THE INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION AND RECEIVED THEIR LIFETIME ACHIEVEMENT AWARD IN 2012. SHE IS ALSO A MASTER OF THE AMERICAN COLLEGE OF CARDIOLOGY. HER TWO-DAY VISIT INCLUDED A GRAND ROUNDS LECTURE, NOON CONFERENCE PRESENTATION AND CASE STUDY PRESENTATIONS WITH CARDIOLOGY FELLOWS.* PRACTICUM IN MECHANICAL CIRCULATORY SUPPORT: MANAGING CARDIOGENIC SHOCK WITH SHORT TERM DEVICES (LOS ANGELES, CA) FRIDAY, OCTOBER 11TH, 2019 THIS 1-DAY SYMPOSIUM ON MECHANICAL CIRCULATORY SUPPORT WAS DEVELOPED IN COLLABORATION WITH CEDARS-SINAI OFFICE OF CONTINUING MEDICAL EDUCATION AND TOOK PLACE ON OCTOBER 11TH, 2019. THE PROGRAM INCLUDED INTERACTIVE DIDACTIC PRESENTATIONS, CASE STUDIES, AND WET-LAB EXPERIENCES, UTILIZING THE CEDARS-SINAI SIMULATION CENTER. THE PROGRAM ALSO FEATURED 5 EXPERT GUEST FACULTY FROM ACROSS THE UNITED STATES PLUS 12 INTERNAL FACULTY. THE PROGRAM DREW 103 ATTENDEES INCLUDING PHYSICIANS, ALLIED HEALTH PROFESSIONALS, NURSE PRACTITIONERS, AND TRANSPLANT COORDINATORS AND PROVIDED LEARNERS WITH A COMPREHENSIVE OVERVIEW OF MECHANICAL CIRCULATORY SUPPORT.* HEART TRANSPLANT VISITING SCIENTISTS: DURING THE LAST CALENDAR YEAR, DR. KOBASHIGAWA HOSTED AND MENTORED VISITING SCIENTISTS FROM OUTSIDE THE U.S., IN AN EFFORT TO FORGE RESEARCH COLLABORATIONS INTERNATIONALLY. VISITING SCIENTISTS SPEND UP TO ONE YEAR ON CAMPUS, DESIGNING AND COMPLETING RESEARCH PROJECTS FOR PUBLICATION AND PRESENTATION, UNDER HIS DIRECT SUPERVISION. IN THE LAST YEAR, THE FOLLOWING PHYSICIAN-INVESTIGATORS COMPLETED EXTENDED VISITS TO OUR PROGRAM:OSAMU SEGUCHI, MD (NATIONAL CEREBRAL & CARDIOVASCULAR CENTER, JAPAN)GUILLAUME COUTANCE, PHD (PARIS TRANSPLANT GROUP, FRANCE)JONG-CHAN YOUN, MD, PHD (SEOUL ST. MARY'S HOSPITAL COLLEGE OF MEDICINE, KOREA)* HEART TRANSPLANT PRECEPTORSHIPS: THROUGHOUT THE YEAR, WE RECEIVE REQUESTS TO PROVIDE EXTENDED OBSERVATIONAL TRAINING OPPORTUNITIES TO PHYSICIANS AND ADVANCE PRACTICE NURSES FROM VARIOUS INSTITUTIONS WITH AN INTEREST IN THE MANAGEMENT OF HEART TRANSPLANT AND MECHANICAL ASSIST DEVICE PATIENTS. IN THE LAST YEAR, WE HOSTED THE FOLLOWING VISITING PHYSICIANS:KIM JIN-JIN, MD (THE CATHOLIC UNIVERSITY OF KOREA, KOREA)CHOI HONG-MI, MD (HALLYM SACRED HEART HOSPITAL, KOREA)HONG JUNG-AE, MD (ASAN MEDICAL CENTER, UNIVERSITY OF ULSAN COLLEGE OF MEDICINE)PRECEPTORSHIPS GENERALLY TAKE PLACE OVER THE COURSE OF A WEEK, DEPENDING ON THE FOCUS OF THE TRAINING. TRAINING INCLUDES PARTICIPATION IN IN-HOSPITAL ROUNDS, OUT-PATIENT CLINIC VISITS, SURGERY/DEVICE IMPLANTATION OBSERVATIONS, DIDACTIC LECTURES, CASE STUDIES, JOURNAL CLUBS AND RESEARCH MEETINGS.* SUMMER RESEARCH INTERNSHIPS: UNDER THE SUPERVISION AND MENTORSHIP OF DR. JON KOBASHIGAWA, SUMMER HEART TRANSPLANT RESEARCH INTERNSHIPS HAVE BEEN OFFERED TO TEN STUDENTS FOR THE SUMMER OF 2019. THESE INTERNSHIPS PROVIDE STUDENTS AT ALL LEVELS OF TRAINING AN OPPORTUNITY TO LEARN THE CLINICAL RESEARCH PROCESS, INCLUDING MEDICAL LITERATURE REVIEW, STUDY DESIGN, CHART REVIEW/DATA COLLECTION, DATA ANALYSIS, AND ABSTRACT DEVELOPMENT AND SUBMISSION. COMPLETED ABSTRACTS WILL BE SUBMITTED TO THE AMERICAN FEDERATION OF MEDICAL RESEARCH, A FORUM FOR JUNIOR INVESTIGATORS. THIS YEAR'S GROUP INCLUDES STUDENTS FROM:UC IRVINE SCHOOL OF MEDICINESACKLER UNIVERSITY TEL AVIV MEDICAL SCHOOLRUSH MEDICAL COLLEGEWESTERN UNIVERSITY COLLEGE OF OSTEOPATHIC MEDICINECALIFORNIA STATE UNIVERSITY MORRO BAYUNIVERSITY OF CALIFORNIA, LOS ANGELESUNIVERSITY OF SOUTHERN CALIFORNIAUNIVERSITY OF CHICAGOUNIVERSITY OF CALIFORNIA, SANTA CRUZ* CURRENT TRENDS IN HEART TRANSPLANTATION: PATIENT EDUCATION SERIES"THIS PATIENT EDUCATION LECTURE BY DR. JON KOBASHIGAWA IS SCHEDULED TWICE A YEAR, COVERING CURRENT TRENDS IN HEART TRANSPLANTATION AND PROVIDING PATIENTS WITH AN OVERVIEW OF CUTTING-EDGE INNOVATIONS IN THE FIELD OF HEART TRANSPLANTATION. FORUMS WERE HELD ON JUNE 10TH, 2019 AND DECEMBER 11TH, 2019 AT THE MEDICAL CENTER AND ATTENDED BY POST-TRANSPLANT PATIENTS AS WELL AS PATIENTS ON THE WAITING LIST FOR TRANSPLANTATION.CLINICAL RESEARCH:THIS SECTION IS FORMATTED BY TITLE; PRINCIPAL INVESTIGATOR (PI); STATUS; SPONSOR.Desc
Total Program Service Expenses$1,954,029TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign Activities0ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To Organizations0GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl EntYes (1)RelatedOrganizationCtrlEntInd
Transaction With Control Ent0TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document13IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee0EmployeeCnt
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members5GoverningBodyVotingMembersCnt
Independent Voting Member3IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or StockholdersYes (1)MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To ApprovaYes (1)DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn Body0Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower Policy0WhistleblowerPolicyInd
Document Retention Policy0DocumentRetentionPolicyInd
Compensation Process CEO0CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1DEBBIE BOTTENBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone3104238473PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line115821 VENTURA BLVD STE 520AddressLine1Txt
CityENCINOCityNm
State AbbreviationCAStateAbbreviationCd
ZIP91436ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (10 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
EDUARDO MARBAN MD
DIRECTOR1.0060.00Yes (X)$0$3,759,190$230,090
THOMAS D GORDON
DIRECTOR1.0040.00Yes (X)$0$99,500$159,456
CHRISTINE SUMBI
SECRETARY40.000.00$0$222,018$30,661Yes (X)
IRINA COZIANU
RESEARCH OPERATIONS MANAGER40.000.00$0$133,717$32,715Yes (X)
VENISE STRAND
PROGRAM MANAGER40.000.00$0$104,871$22,793Yes (X)
PHYLLIS KATZ
EXECUTIVE ASSISTANT40.000.00$0$102,399$22,774Yes (X)
MARIA THOTTAM
CLINICAL RESEARCH COORDINATOR II40.000.00$0$100,742$12,892Yes (X)
JON KOBASHIGAWA MD
PRESIDENT2.000.00Yes (X)$0$0$0Yes (X)
MICHELE HAMILTON
TREASURER2.000.00Yes (X)$0$0$0Yes (X)
JAIME MORIGUCHI MD
DIRECTOR2.000.00Yes (X)$0$0$0
FieldValueIRS element (for citing)
Total Reportable Comp From Org$0TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$4,522,437TotReportableCompRltdOrgAmt
Total Other Compensation$511,381TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K0IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd
Cntrct Rcvd Greater Than100 K0CntrctRcvdGreaterThan100KCnt
Related Organizations$1,944,292RelatedOrganizationsAmt
Total Contributions$1,944,292TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
EDUCATIONAL PROGRAMS611430$256,719$256,719
CULTURAL PROGRAMS611710$9,585$9,585
FieldValueIRS element (for citing)
Total Program Service Revenue$266,304TotalProgramServiceRevenueAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,210,596TotalRevenueColumnAmt
Related Or Exempt Func Income$266,304RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$225,698TotalAmt
Management And General$225,698ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$1,155,693TotalAmt
Program Services$1,155,693ProgramServicesAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$46,438TotalAmt
Program Services$46,438ProgramServicesAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$79,580TotalAmt
Program Services$79,580ProgramServicesAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$91,950TotalAmt
Program Services$91,950ProgramServicesAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$9,985TotalAmt
Program Services$6,990ProgramServicesAmt
Management And General$2,995ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$2,877TotalAmt
Program Services$2,589ProgramServicesAmt
Management And General$288ManagementAndGeneralAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$352,126TotalAmt
Program Services$352,126ProgramServicesAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$220,610TotalAmt
Program Services$209,580ProgramServicesAmt
Management And General$11,030ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
MEALS AND ENTERTAINMENT$9,866$3,354$6,512
MOVING/STORAGE$2,140$2,140
BANK CHARGES$1,800$1,800
CREDIT CARD FEES$823$823

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$1,741TotalAmt
Program Services$966ProgramServicesAmt
Management And General$775ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$2,201,327TotalAmt
Program Services$1,954,029ProgramServicesAmt
Management And General$247,298ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$24,760BOYAmt
EOY$71,669EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$19,015BOYAmt
EOY$7,511EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$107,678LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$107,678LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$43,775BOYAmt
EOY$79,180EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$205,011BOYAmt
EOY$228,630EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$2,982BOYAmt
EOY$5,500EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$207,993BOYAmt
EOY$234,130EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY-$164,218BOYAmt
EOY-$154,950EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY-$164,218BOYAmt
EOY-$154,950EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$43,775BOYAmt
EOY$79,180EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$9,269ReconcilationRevenueExpnssAmt
Other Changes In Net Assets-$1OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS Audited0FSAuditedInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,784,016CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,531,356CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,466,549CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,603,657CurrentTaxYearMinus1YearAmt
Current Tax Year$1,944,292CurrentTaxYearAmt
Total$8,329,870TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,784,016CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,531,356CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,466,549CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,603,657CurrentTaxYearMinus1YearAmt
Current Tax Year$1,944,292CurrentTaxYearAmt
Total$8,329,870TotalAmt
FieldValueIRS element (for citing)
Public Support Total170$8,329,870PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,031CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$6CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$0CurrentTaxYearMinus1YearAmt
Current Tax Year$0CurrentTaxYearAmt
Total$1,037TotalAmt
FieldValueIRS element (for citing)
Total Support$8,330,907TotalSupportAmt
Gross Receipts Rltd Activities$1,156,187GrossReceiptsRltdActivitiesAmt
Public Support CY1700.99990PublicSupportCY170Pct
Public Support PY1700.99920PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$70,594OtherCostOrOtherBasisAmt
Depreciation$70,594DepreciationAmt
Book Value$0BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$37,084OtherCostOrOtherBasisAmt
Depreciation$37,084DepreciationAmt
Book Value$0BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$0TotalBookValueLandBuildingsAmt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (1)SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (4 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
EDUARDO MARBAN MD
DIRECTOR$0$1,906,529$0$515,772$0$1,336,889$0$196,788$0$33,302$0$3,989,280$0$600,000
THOMAS D GORDON
DIRECTOR$0$0$0$0$0$99,500$0$159,456$0$0$0$258,956$0$0
CHRISTINE SUMBI
SECRETARY$0$182,307$0$33,246$0$6,465$0$18,026$0$12,635$0$252,679$0$0
IRINA COZIANU
RESEARCH OPERATIONS MANAGER$0$116,591$0$17,126$0$0$0$7,448$0$25,267$0$166,432$0$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 3PLEASE SEE SCHEDULE O NARRATIVE FOR PART VI, SECTION B LINE 15B.
PART I, LINE 4BTHE PLAN IS A SUPPLEMENTAL RETIREMENT ALLOWANCE THAT IS PAYABLE DIRECTLY TO THE PARTICIPANTS EACH QUARTER. THE BENEFIT FORMULA FOR THIS PLAN HAS ANNUAL CONTRIBUTIONS THAT ARE EITHER A PERCENTAGE OF SALARY, OR ARE DESIGNED TO FUND A PERCENTAGE OF THE ESTIMATED FINAL 5-YEAR AVERAGE SALARY. IN ADDITION, ONE INDIVIDUAL HAD RETENTION INCENTIVES WHICH HAD CLIFF-VESTING DATE IN 2019. THE FOLLOWING DIRECTOR AND OFFICER RECEIVED PAYMENTS DURING THE YEAR ENDED DECEMBER 31, 2019: CHRISTINE SUMBI 6,185 EDUARDO MARBAN, MD 1,166,914

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (10 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE:(CONTINUED) A PILOT RANDOMIZED STUDY TO ASSESS THE EFFECT AND SAFETY PROFILE OF THYMOGLOBULIN IN PRIMARY CARDIAC TRANSPLANT RECIPIENTS: A 12-MONTH, SINGLE CENTER, RANDOMIZED OPEN-LABEL STUDY OF EFFICACY COMPARING IMMEDIATE TREATMENT WITH AND WITHOUT THYMOGLOBULIN 1.5MG/KG/D FOR 5 CONSECUTIVE DAYS IN HEART TRANSPLANT RECIPIENTS; KOBASHIGAWA; ENROLLING; SANOFI TARGETING INFLAMMATION AND ALLOIMMUNITY IN HEART TRANSPLANT RECIPIENTS WITH TOCILIZUMAB; KOBASHIGAWA; ENROLLING; NIH/MGH RISK FACTORS AND OUTCOMES IN ADVANCED HEART DISEASE (REGISTRY STUDY); KOBASHIGAWA; ENROLLING; INTERNAL KCCQ - QUALITY OF LIFE SURVEY STUDY; KOBASHIGAWA; ENROLLING; INTERNAL CARDIAC SURGERY AFTER HEART TRANSPLANTATION - AN EXPLORATORY, RETROSPECTIVE, MULTICENTER STUDY (CASH-STUDY);KOBASHIGAWA; FINAL ANALYSIS PENDING; MEDICAL UNIVERSITY OF VIENNA EXTERNAL FACTORS AND OUTCOMES FOR HEART TRANSPLANT RECIPIENTS: A SINGLE CENTER SURVEY STUDY; KOBASHIGAWA; ENROLLING; INTERNAL SURVEILLANCE HEARTCARE OUTCOMES REGISTRY STUDY (SHORE); KOBASHIGAWA; ENROLLING; CAREDX A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY (GALACTIC-HF) ASSESS THE EFFICACY AND SAFETY OF OMECAMTIV MECARBIL ON MORTALITY AND MORBIDITY IN SUBJECTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION; CHANG; ENROLLMENT AND FOLLOW-UP VISITS COMPLETE; PENDING DATA LOCK AND ANALYSIS; AMGEN A DOUBLE-BLIND, RANDOMIZED, SHAM-PROCEDURE-CONTROLLED, PARALLEL-GROUP EFFICACY AND SAFETY STUDY OF ALLOGENEIC MESENCHYMAL PRECURSOR CELLS IN PATIENTS WITH CHRONIC HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION OF EITHER ISCHEMIC OR NON ISCHEMIC ETIOLOGY: DREAM HF-1; CHANG; ENROLLMENT AND FOLLOW-UP VISITS COMPLETE; PENDING DATA LOCK AND ANALYSIS; MESOBLAST, INC. RANDOMIZED CONTROLLED PIVOTAL TRIAL OF AUTOLOGOUS BONE MARROW MONONUCLEAR CELLS USING THE CARDIAMP CELL THERAPY IN PATIENTS WITH POST MYOCARDIAL INFARCTION HEART FAILURE (CARDIAMP HEART FAILURE TRIAL); CHANG; ENROLLING; BIOCARDIA CONTINUED ACCESS PROTOCOL TO COLLECT ADDITIONAL EVIDENCE TO EVALUATE THE SAFETY AND EFFECTIVENESS OF THE PORTABLE ORGAN CARE SYSTEM (OCS) HEART FOR PRESERVING AND ASSESSING EXPANDED CRITERIA DONOR HEARTS FOR TRANSPLANTATION (HEART EXPAND CAP); ESMAILIAN; ENROLLING; TRANSMEDICS HEART INSTITUTE BIOBANK STUDY; HAMILTON; ENROLLING; INTERNAL RELIEVE-HF TRIAL: REDUCING LUNG CONGESTION SYMPTOMS USING THE V-WAVE SHUNT IN ADVANCED HEART FAILURE; HAMILTON; ENROLLING; V-WAVE THE FREQUENCY AND SIGNIFICANCE OF BLOOD TYPE A1 DONORS TO NON-A1 SUBGROUP RECIPIENTS IN HEART TRANSPLANTATION; KITTLESON; ENROLLING; INTERNAL TRANSPLANT OF REDEEMED ORGANS BY JUDICIOUS ADMINISTRATION OF NEW DIRECT-ACTING ANTIVIRALS FOR HEPATITIS-C HEART RECIPIENTS (TROJAN-C); KRANSDORF; ENROLLING; BAYLOR UNIVERSITY/ONE LEGACY HEART FAILURE CLINICAL RESEARCH NETWORK ENTRESTO (LCZ696) IN ADVANCED HEART FAILURE (LIFE STUDY); KRANSDORF; ENROLLMENT AND FOLLOW-UP VISITS COMPLETE; PENDING DATA LOCK AND ANALYSIS; DUKE UNIVERSITY DILATED CARDIOMYOPATHY (DCM) RESEARCH PROJECT; KRANSDORF; ENROLLING; OHIO UNIVERSITY B3461045: A PHASE 3 MULTICENTER, OPEN LABEL STUDY TO EVALUATE THE SAFETY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826-83) 20 MG OR 80 MG [OR TAFAMIDIS (PF-06291826-00) 61 MG] IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (ATTR-CM); PATEL; ENROLLMENT COMPLETE; FOLLOW-UP VISITS ONLY; PFIZER CARDIAC AMYLOIDOSIS REGISTRY STUDY; PATEL; ENROLLING; INTERNAL
FORM 990, PART IV, LINE 12THE ORGANIZATION WAS INCLUDED IN A CONSOLIDATED, INDEPENDENT AUDITED FINANCIAL STATEMENTS FOR THE FISCAL YEARS ENDED 6/30/19 AND 6/30/20 DUE TO THE FACT THAT THE TAX YEAR OF ITS TAX-EXEMPT PARENT ORGANIZATION, CEDARS-SINAI MEDICAL CENTER, ENDS ON 6/30. THERE ARE NO AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 12/31/19.
FORM 990, PART VI, SECTION A, LINE 6CEDARS-SINAI MEDICAL CENTER IS THE SOLE CORPORATE MEMBER OF CALIFORNIA HEART CENTER FOUNDATION.
FORM 990, PART VI, SECTION A, LINE 7ACEDARS-SINAI MEDICAL CENTER AS THE SOLE CORPORATE MEMBER, CAN ELECT BOARD OF DIRECTORS TO CALIFORNIA HEART CENTER FOUNDATION.
FORM 990, PART VI, SECTION A, LINE 7BRESERVED RIGHTS OF CEDARS-SINAI MEDICAL CENTER, THE SOLE CORPORATE MEMBER OF THE ORGANIZATION. THE FOLLOWING ACTIONS MUST BE APPROVED OR ACTED UPON BY CEDARS-SINAI MEDICAL CENTER BEFORE BECOMING EFFECTIVE: (A) ANY SALE OR OTHER DISPOSITION OF ALL OR A SUBSTANTIAL PORTION OF THE ASSETS OF THE ORGANIZATION; (B) ANY MERGER OR AFFILIATION OF THE ORGANIZATION WITH ANY PERSON OR ENTITY OTHER THAN THE MEMBER; (C) ANY AMENDMENT TO THE ARTICLES OF INCORPORATION OR BYLAWS OF THE ORGANIZATION; (D) ANY ACT OR OMISSION WHICH CREATES ANY MATERIAL RISK TO THE MEMBER'S TAX EXEMPT STATUS, OR CREATES ANY MATERIAL RISK OF A VIOLATION OF ANY STATE OR FEDERAL LAWS; (E) DISSOLUTION OF THE ORGANIZATION OR THE FILING OF ANY BANKRUPTCY PETITION; (F) CREATION OF ANY NEW CORPORATION, PARTNERSHIP OR ASSOCIATION; (G) ACQUISITION OF OR THE INVESTMENT IN A NEW OPERATING BUSINESS; (H) ENTERING INTO ANY PARTNERSHIPS OR JOINT VENTURES; (I) ADOPTION OF OR CHANGES TO OPERATING OR CAPITAL BUDGETS; (J) ADOPTION OF THIS CORPORATION'S POLICIES AND PROCEDURES; (K) EXECUTION AND DELIVERY OF ANY NEW AFFILIATION AGREEMENTS AND OTHER RELATIONSHIPS WITH THE UCLA SCHOOL OF MEDICINE AND OTHER INSTITUTIONS OF MEDICAL LEARNING; (L) UNBUDGETED CAPITAL EXPENDITURES OVER $100,000; (M) LOANS, BORROWINGS OR GUARANTEES IN EXCESS OF $100,000, UNLESS APPROVED IN THE BUDGET; (N) ANY SECURITY INTERESTS OR MORTGAGES ON THE PROPERTY OF ORGANIZATION; (O) OPERATING OR CAPITAL LEASES WHERE THE TERM IS OVER FIVE YEARS OR THE TOTAL OBLIGATION UNDER THE LEASE EXCEEDS $100,000, UNLESS APPROVED IN THE BUDGET; (P) TERMINATION OR SELECTION OF THE AUDITORS OF THE ORGANIZATION; (Q) APPOINTMENT OR REMOVAL OF ANY MEMBER OF THE BOARD (OTHER THAN EX-OFFICIO DIRECTORS); (R) APPOINTMENT OF REMOVAL OF ANY OFFICERS; (S) EXECUTION AND DELIVERY OF ANY PROFESSIONAL SERVICE AGREEMENTS; (T) RELOCATION OF PRINCIPAL OFFICE; AND (U) FIXING THE NUMBER OF DIRECTORS OF THE ORGANIZATION.
FORM 990, PART VI, SECTION B, LINE 11BTHE ORGANIZATION'S FORM 990 UNDERGOES AN INTENSE AND HIGHLY COMPREHENSIVE REVIEW PROCESS. THE REVIEW INVOLVES VARIOUS MANAGEMENT PERSONNEL AND A BIG FOUR ACCOUNTING FIRM.
FORM 990, PART VI, SECTION B, LINE 12CCONFLICT OF INTEREST POLICY ANNUAL STATEMENTS: EACH DIRECTOR, OFFICER, MEMBER OF A COMMITTEE WITH BOARD-DELEGATED POWERS AND ANY OTHER INTERESTED PERSON AS DETERMINED BY THE BOARD OR COMMITTEE SHALL AT LEAST ANNUALLY SIGN A COPY OF THE "STATEMENT PERTAINING TO CONFLICT OF INTEREST." IF A DIRECTOR, OFFICER, OR COMMITTEE MEMBER, OR DESIGNATED INTERESTED PERSON BECOMES AWARE THAT A POTENTIAL OR APPARENT CONFLICT MAY EXIST WHICH IS NOT DISCLOSED ON SUCH A STATEMENT, IT SHALL BE THE RESPONSIBILITY OF THE INTERESTED PERSON TO DISCLOSE THE POTENTIAL CONFLICT TO THE PRESIDENT AND TO THE BOARD OR APPROPRIATE COMMITTEE AND AS SET FORTH ABOVE, PRIOR TO ANY BOARD OR COMMITTEE DISCUSSIONS OR ACTION WITH RESPECT TO THE RELEVANT TRANSACTION OR ARRANGEMENT, AND, IF RELEVANT, TO LEAVE THE MEETING DURING THE DISCUSSION AND VOTE ON THE TRANSACTION OR ARRANGEMENT. DETERMINING WHETHER A CONFLICT OF INTEREST EXISTS: IF CONSIDERATION OF THE TRANSACTION OR ARRANGEMENT AT ISSUE IS A MATTER WITHIN THE SCOPE OF AUTHORITY OF THE BOARD OF DIRECTORS OR A COMMITTEE, AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, THE RELEVANT CALIFORNIA HEART CENTER FOUNDATION ("CHCF") OFFICER OR ADMINISTRATOR SHALL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS. IF IT IS DETERMINED THAT A CONFLICT OF INTEREST EXISTS AND, NOTWITHSTANDING THE CONFLICT, THE CHCF OFFICER OR ADMINISTRATOR DETERMINES THAT IT CONTINUES TO BE IN THE BEST INTERESTS OF CHCF TO PROCEED WITH THE TRANSACTION OR ARRANGEMENT AT ISSUE, THE CHCF OFFICER OR ADMINISTRATOR SHALL REFER THE TRANSACTION OR ARRANGEMENT TO THE BOARD OR THE APPROPRIATE BOARD-DESIGNATED COMMITTEE FOR EVALUATION. ALTERNATIVELY IF CONSIDERATION OF THE TRANSACTION OR ARRANGEMENT AT ISSUE IS A MATTER WITHIN THE SCOPE OF THE AUTHORITY OF THE BOARD OF DIRECTORS OR A COMMITTEE, THE INTERESTED PERSON SHALL LEAVE THE BOARD OR COMMITTEE MEETING WHILE THE DETERMINATION OF THE EXISTENCE OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD OR COMMITTEE MEMBERS SHALL DECIDE, BY MAJORITY VOTE, IF A CONFLICT OF INTEREST EXISTS. PROCEDURES FOR ADDRESSING THE CONFLICT OF INTEREST: A. AN INTERESTED PERSON MAY MAKE A PRESENTATION TO THE BOARD OR COMMITTEE REGARDING THE TRANSACTION OR ARRANGEMENT. AFTER SUCH PRESENTATION THE INTERESTED PERSON MUST LEAVE THE MEETING DURING THE DISCUSSION OF, AND THE VOTE ON THE TRANSACTION OR ARRANGEMENT. B. THE CHAIR OF THE BOARD OR COMMITTEE SHALL, IF DEEMED APPROPRIATE BY THE BOARD OR COMMITTEE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. C. AFTER EXERCISING DUE DILIGENCE, THE BOARD OR COMMITTEE SHALL DETERMINE WHETHER CHCF CAN OBTAIN A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT WITH REASONABLE EFFORTS FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. D. IF A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY ATTAINABLE UNDER CIRCUMSTANCES THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST, THE BOARD OR COMMITTEE SHALL DETERMINE BY A MAJORITY VOTE OF THE DISINTERESTED DIRECTORS WHETHER THE TRANSACTION OR ARRANGEMENT IS IN CHCF' BEST INTEREST AND FOR ITS OWN BENEFIT AND WHETHER THE TRANSACTION IS FAIR AND REASONABLE TO CHCF AND SHALL MAKE ITS DECISION AS TO WHETHER TO ENTER INTO THE TRANSACTION OR ARRANGEMENT IN CONFORMITY WITH SUCH DETERMINATION. VIOLATIONS OF THE CONFLICTS POLICY: A. IF THE BOARD OR COMMITTEE HAS REASONABLE CAUSE TO BELIEVE THAT A MEMBER OF THE BOARD OR COMMITTEE OR AN OFFICER OR OTHER INTERESTED PERSON HAS FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, IT SHALL INFORM THE MEMBER OR OFFICER OR INTERESTED PERSON OF THE BASIS FOR SUCH BELIEF AND AFFORD SUCH PERSON AN OPPORTUNITY TO EXPLAIN THE ALLEGED FAILURE TO DISCLOSE. B. IF, AFTER HEARING THE RESPONSE OF SUCH PERSON AND MAKING SUCH FURTHER INVESTIGATION AS MAY BE WARRANTED IN THE CIRCUMSTANCES, THE BOARD OR COMMITTEE DETERMINES THAT SUCH PERSON HAS IN FACT FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, IT SHALL TAKE APPROPRIATE DISCIPLINARY AND CORRECTIVE ACTION.
FORM 990, PART VI, SECTION B, LINE 15BTHE EXECUTIVE PERSONNEL COMMITTEE (THE COMMITTEE) OF THE TAX-EXEMPT PARENT OF THE ORGANIZATION, CEDARS-SINAI MEDICAL CENTER, IS A STANDING COMMITTEE OF THE BOARD OF DIRECTORS. THE COMMITTEE ADDRESSES COMPENSATION AND BENEFITS REGARDING THE ORGANIZATION'S CHIEF FINANCIAL OFFICER AND BOARD MEMBERS WHO ARE ALSO EXECUTIVE EMPLOYEES AND CONTRACTUALLY ENGAGED FACULTY OF THE MEDICAL CENTER, AND IS AUTHORIZED BY THE BOARD OF DIRECTORS TO ACT ON BEHALF OF THE BOARD WITH RESPECT TO SUCH ISSUES, AND OTHER GOVERNANCE ISSUES AS REQUESTED BY THE BOARD OF DIRECTORS, THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, THE CHAIR OF THE BOARD OF DIRECTORS, OR THE CEO, ALL SUBJECT TO THE COMMITTEE'S ONGOING REPORTING OBLIGATION TO THE BOARD OF DIRECTORS OR THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS. SPECIFICALLY, THE COMMITTEE EVALUATES THE PERFORMANCE AND APPROVES THE COMPENSATION AND BENEFITS FOR THE ORGANIZATION'S CHIEF FINANCIAL OFFICER AND BOARD MEMBERS WHO ARE ALSO EXECUTIVE EMPLOYEES AND CONTRACTUALLY ENGAGED FACULTY OF THE MEDICAL CENTER. THE MEMBERS OF THE COMMITTEE ARE APPOINTED ANNUALLY BY THE CHAIR OF THE MEDICAL CENTER'S BOARD OF DIRECTORS. APPOINTMENTS ARE FOR A ONE YEAR TERM. EACH YEAR, THE COMMITTEE FOLLOWS A PROCESS THAT ENSURES THAT THE COMPENSATION AND BENEFITS IS REASONABLE AND IN COMPLIANCE WITH APPLICABLE LAWS AND REGULATIONS. THE MEDICAL CENTER'S SVP OF HR PROVIDES STAFF SUPPORT TO THE COMMITTEE. THE COMMITTEE MAY INCLUDE MEMBERS OF THE MEDICAL CENTER'S MANAGEMENT TEAM OR ANY OTHER PERSON WHOSE PRESENCE THE COMMITTEE BELIEVES TO BE DESIRABLE OR APPROPRIATE. THE COMMITTEE MAY ENGAGE AN INDEPENDENT COMPENSATION AND BENEFITS CONSULTANT AND ANY OTHER ADVISORS THEY DEEM NECESSARY. THE COMMITTEE MAY ALSO ENGAGE INDEPENDENT COUNSEL. THE MEDICAL CENTER WILL PROVIDE FOR APPROPRIATE FUNDING FOR PAYMENT OF COSTS TO ANY SUCH PERSONS RETAINED BY THE COMMITTEE. ANNUALLY, AT THE COMMITTEE'S DIRECTION, THE INDEPENDENT COMPENSATION CONSULTANT SHALL PREPARE SUCH REPORTS AS THE COMMITTEE REASONABLY DEEMS NECESSARY. AT A MINIMUM, SUCH REPORTS WILL INCLUDE MARKET SURVEY DATA FROM A PEER GROUP DESIGNATED BY THE COMMITTEE, WHICH SHALL BE CONSIDERED BY THE COMMITTEE PRIOR TO MAKING DECISIONS. THE COMMITTEE MEETS AS FREQUENTLY AS THE COMMITTEE DEEMS NECESSARY AND WILL MAINTAIN WRITTEN MINUTES OF ITS MEETING. THE COMPENSATION AND BENEFITS OF THE PRESIDENT AND VICE-PRESIDENT ARE DETERMINED BY THE CHIEF FINANCIAL OFFICER OF THE ORGANIZATION WITH ASSISTANCE FROM HR WHICH PROVIDES AN INDEPENDENT REVIEW OF COMPARABLES.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, ITS CONFLICT OF INTEREST POLICY AND ITS TAX-EXEMPT PARENT'S AUDITED FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON WRITTEN REQUEST.
FORM 990, PART XI, LINE 9:ROUNDING -1.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (9 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdExempt Code SectionExemptCodeSectionTxtPublic Charity StatusPublicCharityStatusTxtBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtControlled OrganizationControlledOrganizationIndDirect Controlling NADirectControllingNACd
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BOULEVARDLOS ANGELESCA90048951644600ACUTE-CARE, TEACHING AND RESEARCH HOSPITALCA501(C)(3)LINE 3CEDARS-SINAI HEALTH SYSTEM0
CEDARS-SINAI MEDICAL CARE FOUNDATION
15821 VENTURA BLVD STE 520ENCINOCA91436954457756PROVISION OF MEDICAL CARE, TEACHING AND RESEARCHCA501(C)(3)LINE 12A, ICEDARS-SINAI MEDICAL CENTERYes (1)
KERLAN-JOBE ORTHOPAEDIC FOUNDATION
6801 PARK TERRACE 500LOS ANGELESCA90045954707606EDUCATION AND RESEARCH RELATED TO ORTHOPAEDIC MEDICINECA501(C)(3)LINE 7CEDARS-SINAI MEDICAL CARE FOUNDATIONYes (1)
SANTA MONICA ORTHOPAEDIC & SPORTS MED RESEARCH FDN
2020 SANTA MONICA BLVD 4TH FLRSANTA MONICACA90404954789926EDUCATION AND RESEARCH RELATED TO ORTHOPAEDIC AND NEUROLOGIC CONDITIONSCA501(C)(3)PFCEDARS-SINAI MEDICAL CARE FOUNDATIONYes (1)
CFHS HOLDINGS INC
4650 LINCOLN BLVDMARINA DEL REYCA90292201645949HEALTHCARECA501(C)(3)LINE 3CEDARS-SINAI MEDICAL CENTERYes (1)
CEDARS-SINAI HEALTH SYSTEM
8700 BEVERLY BOULEVARDLOS ANGELESCA90048300990905SUPPORT SPECIFIED NONPROFIT HEALTHCARE ORGANIZATIONSCA501(C)(3)LINE 12C, III-FI0N/A
TORRANCE HEALTH ASSOCIATION
23326 HAWTHORNE BLVD STE 300TORRANCECA90505330073515HEALTH SERVICESCA501(C)(3)LINE 12B, IICEDARS-SINAI HEALTH SYSTEMYes (1)
TORRANCE MEMORIAL MEDICAL CENTER HEALTH CARE FOUNDATION
3330 LOMITA BLVDTORRANCECA90505953528452FUNDRAISINGCA501(C)(3)LINE 7TORRANCE HEALTH ASSOCIATIONYes (1)
TORRANCE MEMORIAL MEDICAL CENTER
3330 LOMITA BLVDTORRANCECA90505951644042HEALTH SERVICESCA501(C)(3)LINE 3TORRANCE HEALTH ASSOCIATIONYes (1)

Id Related Org Txbl Partnership IdRelatedOrgTxblPartnershipGrp (10 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdDirect Controlling NADirectControllingNACd
ENDOSCOPY CENTER OF SANTA MONICA LLC
12400 WILSHIRE BLVD STE 100LOS ANGELESCA90025113652210ENDOSCOPIES AND RELATED PROCEDURESCAN/A
ISS ASC HOLDINGS LLC
200 N ROBERTSON BLVD STE 101BEVERLY HILLSCA90211471890805INVESTMENT IN HEALTHCARE SERVICESCAN/A
DEL REY SURGERY INVESTORS LLC
6500 WILSHIRE BLVD 9TH FLLOS ANGELESCA90048364756208INVESTMENT IN AMBULATORY SURGERY CENTERDEN/A
DEL REY SURGERY CENTER LLC
6500 WILSHIRE BLVD 9TH FLLOS ANGELESCA90048462305372AMBULATORY SURGERY CENTERCAN/A
CS-BH ASC HOLDINGS LLC
200 N ROBERTSON BLVD STE 101BEVERLY HILLSCA90211812246488HOLDING COMPANYCAN/A
INTERNATIONAL SPINE & ORTHOPEDIC INSTITUTE LLC
8500 W 110TH STOVERLAND PARKKS66210263738893SPINE AND ORTHOPEDIC INSTITUTEDEN/A
SANTA MONICA IMAGING GROUP LLC
200 N ROBERTSON BLVD STE 101BEVERLY HILLSCA90211820760657IMAGING CENTERCAN/A
TORRANCE MEMORIAL SURGICAL CENTER LLC I
23560 CRENSHAW BLVD STE 104TORRANCECA90505465259260OUTPATIENT SURGICAL SERVICESCAN/A
3565 DEL AMO ASSOCIATES A CALIFORNIA LIMITED PARTNERSHIP
5017 CARMEN STREETTORRANCECA90503330554737RENTAL REAL ESTATECAN/A
90210 ASC VENTURE LLC
200 N ROBERTSON BLVD STE 101BEVERLY HILLSCA90211134341801AMBULATORY SURGERY CENTERCAN/A

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (3 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdDirect Controlling NADirectControllingNACdEntity TypeEntityTypeTxtControlled OrganizationControlledOrganizationInd
OPTIMATRIX HEALTH SOLUTIONS INC
6500 WILSHIRE BLVD 9TH FLRLOS ANGELESCA90048954522779INACTIVECAN/ACYes (1)
CENTINELA FREEMAN HOLDINGS INC
8700 BEVERLY BLVD STE TSB-290LOS ANGELESCA90048593811890REAL ESTATE RENTALSCAN/ACYes (1)
OTOHARMONICS CORPORATION
411 SW 6TH AVEPORTLANDOR97204461119421HEALTHCARE PRODUCT DEVELOPMENTDEN/ACYes (1)
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org0GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgYes (1)GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (1)SharingOfFacilitiesInd
Paid Employees SharingYes (1)PaidEmployeesSharingInd
Reimbursement Paid To Other OrgYes (1)ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.